(Q47554972)

3 February 2018

title

An assessment of shedding with the oral rabies virus vaccine strain SPBN GASGAS in target and non-target species (English)

1 reference

3 February 2018

0 references

rabies virus

1 reference

2

Conrad Freuling

1 reference

3 February 2018

Ad Vos

1

1 reference

3 February 2018

Steffen Ortmann

3

1 reference

3 February 2018

Antje Kretzschmar

4

1 reference

3 February 2018

Dietmar Mayer

5

1 reference

3 February 2018

Annette Schliephake

6

1 reference

3 February 2018

Thomas Müller

7

1 reference

3 February 2018

language of work or name

English

0 references

publication date

8 January 2018

1 reference

3 February 2018

published in

Vaccine

1 reference

3 February 2018

Terrestrial rabies control in the European Union: historical achievements and challenges ahead

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.076

Spatio-temporal Use of Oral Rabies Vaccines in Fox Rabies Elimination Programmes in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.076

Oral vaccination of wildlife against rabies: Differences among host species in vaccine uptake efficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.076

The final stages of the global eradication of poliomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.076

Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.076

Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.076

Rotavirus vaccines: viral shedding and risk of transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.076

Oral immunization of raccoons and skunks with a canine adenovirus recombinant rabies vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.076

Human infection due to recombinant vaccinia-rabies glycoprotein virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.076

A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.076

Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.076

Dominance of a nonpathogenic glycoprotein gene over a pathogenic glycoprotein gene in rabies virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.076

Improved safety for molecular diagnosis of classical rabies viruses by use of a TaqMan real-time reverse transcription-PCR "double check" strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.076

An update on safety studies of SAD B19 rabies virus vaccine in target and non-target species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.076

Primary multiplication site of the vaccinia-rabies glycoprotein recombinant virus administered to foxes by the oral route

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.076

Rapid clearance of SAG-2 rabies virus from dogs after oral vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.076

Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.076

Characterization of a human adenovirus 5: rabies glycoprotein recombinant vaccine reisolated from orally vaccinated skunks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.076

Safety studies on an adenovirus recombinant vaccine for rabies (AdRG1.3-ONRAB) in target and non-target species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.076

An assessment of ONRAB oral rabies vaccine persistence in free-ranging mammal populations in Ontario, Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.076

Survival of African Swine Fever Virus in Excretions from Pigs Experimentally Infected with the Georgia 2007/1 Isolate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.076

10.1016/J.VACCINE.2017.12.076

7 January 2021

Identifiers

DOI

1 reference

3 February 2018

1 reference

3 February 2018